UPDATE 1-AstraZeneca to buy Actavis lung drugs as Q4 earnings fall short
February 05, 2015 at 03:20 AM EST
* Q4 core EPS 76 cents vs consensus 82 cents (Adds further details on Actavis deal, more on outlook, shares)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.